Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Leases: 2022-2025

Historic Current Leases for Biodesix (BDSX) over the last 4 years, with Sep 2025 value amounting to $1.4 million.

  • Biodesix's Current Leases rose 123.40% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 123.40%. This contributed to the annual value of $719,000 for FY2024, which is 185.32% up from last year.
  • Per Biodesix's latest filing, its Current Leases stood at $1.4 million for Q3 2025, which was up 13.15% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Current Leases peaked at $1.8 million during Q1 2023, and registered a low of $252,000 during Q4 2023.
  • In the last 3 years, Biodesix's Current Leases had a median value of $1.1 million in 2025 and averaged $933,273.
  • As far as peak fluctuations go, Biodesix's Current Leases crashed by 84.56% in 2024, and later skyrocketed by 310.67% in 2025.
  • Quarterly analysis of 4 years shows Biodesix's Current Leases stood at $1.5 million in 2022, then crashed by 83.67% to $252,000 in 2023, then skyrocketed by 185.32% to $719,000 in 2024, then skyrocketed by 123.40% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.2 million for Q2 2025, and $1.1 million during Q1 2025.